EWASdb: epigenome-wide association study database

       EWASdb : epigenome-wide association study database


EWAS for single marker      EWAS for KEGG Pathway      EWAS for GO Category      Browers by class      Browers by alph      FAQ

The data is big,please wait a moment......

Search Result for GO Categories

Total 1094 records 53/110 page first << upPage 5152 535455 downPage >> last

EWAS ID GO ID Class Disease/Phenotype
[sample size n]		 Sample groups
(case/control, trait, cell type etc.)		 Categories GO Term Name GO Term Gene Number Gene Number Annotated In The GO Term Pvalue
Group1
[sample size n]		 Group2
[sample size n]
EWAS1296 GO:0018108 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 biological_process peptidyl-tyrosine phosphorylation 115 98 0.000009
EWAS1296 GO:0018130 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 biological_process heterocycle biosynthetic process 341 265 0.000038
EWAS1296 GO:0018149 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 biological_process peptide cross-linking 24 23 0.000104
EWAS1296 GO:0018193 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 biological_process peptidyl-amino acid modification 435 329 0.000264
EWAS1296 GO:0018212 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 biological_process peptidyl-tyrosine modification 117 100 0.000005
EWAS1296 GO:0019198 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 molecular_function transmembrane receptor protein phosphatase activity 15 15 0.000000
EWAS1296 GO:0019199 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 molecular_function transmembrane receptor protein kinase activity 80 78 0.000000
EWAS1296 GO:0019216 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 biological_process regulation of lipid metabolic process 133 110 0.000051
EWAS1296 GO:0019220 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 biological_process regulation of phosphate metabolic process 618 478 0.000000
EWAS1296 GO:0019221 disease multiple sclerosis
[n=96]		 multiple sclerosis patients treated with fumaric acid esters(FAE)
[n=42]		 untreated/treatment naive multiple sclerosis patients(Naive)
[n=54]		 biological_process cytokine-mediated signaling pathway 189 151 0.000120

Total 1094 records 53/110 page first << upPage 5152 535455 downPage >> last